Meta stock is still worthy of a "Buy" rating given its strong Q4 revenue and ad growth. Here's what investors need to ...
Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...